This opportunity is no longer accepting applications.
grant PAR-22-219

Biology of Bladder Cancer (R21 Clinical Trial Optional)

This grant opportunity is for research on the biology and mechanisms behind bladder cancer. Bladder cancer poses a large health challenge due to its high occurrence and tendency to recur. There have been advances in understanding the genetic mutations associated with bladder cancer, but less is known about the molecular processes that drive its development and progression. Additionally, there'…

This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder can…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Awards & funding

Award Ceiling: $275,000
Award Amount: $275,000

Dates

Open for Submission: July 26, 2022
Submission Deadline: September 7, 2025
Application Window Closes: September 7, 2025
Opportunity Released: July 26, 2022

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.